In the Boardroom
Refine Search
Pharmaceutical
Bayer today announced the appointment of Dr Carsten Brunn as president of its pharmaceuticals business in the Americas, comprising the USA, Canada, Central and Latin America. 17 January 2017
Pharmaceutical
UK specialty pharma company Diurnal has announced the appointment of Richard Bungay as chief financial officer (CFO). 12 January 2017
Biotechnology
Friday saw the launch of a new US biotech company, Vir Biotechnology, which is focussed developing cures, treatments and preventions for challenging infectious diseases, with former Biogen chief executive George Scangos heading a team of scientific and industry leaders. 9 January 2017
Biotechnology
3SBio announced today that Zhenping Zhu will join the Chinese biotech firm as president of research & development and chief scientific officer. 9 January 2017
Pharmaceutical
The new man at the helm of Eli Lilly has started off his time as the US pharma major’s chief executive by announcing a series of organizational and leadership structure changes. 6 January 2017
Pharmaceutical
Germany-based MorphoSys has appointed Dr Malte Peters as chief development officer. 6 January 2017
Biotechnology
David-Alexandre “DA” Gros has joined Neurocrine Biosciences as president and chief operating officer, the American biotech group announced today. 6 January 2017
Biotechnology
Biotech firm Sobi have announced the recruitment of Armin Reininger as senior vice president and head of global medical and scientific affairs. 5 January 2017
Biotechnology
US-based biotech firm Gilead has recruited Alessandro Riva as senior vice president of hematology and oncology. Dr Riva helped develop more than 20 cancer compounds as head of oncology at Swiss giant Novartis, including both targeted and immune-oncology treatments. 4 January 2017
Biotechnology
Ireland-headquartered Shire has announced the appointment of Ian Clark as a non-executive director of the company with effect from today (January 3). 3 January 2017
Pharmaceutical
Provectus Biopharmaceuticals has said that, on December 27, 2016, its board of directors unanimously voted to terminate Peter Culpepper, effective immediately, from all positions held with the company, including chief executive and chief operating officer. 30 December 2016
Pharmaceutical
US fertility treatment specialist OvaScience lost nearly a third of its value after it announced major workforce cuts and the departure of two top executives. 22 December 2016
Pharmaceutical
News that AstraZeneca was losing the experienced head of one its focus areas caused a slight share price wobble on Monday – but the company is confident that his shoes will be ably filled. 21 December 2016
Biotechnology
The share price of AstraZeneca has suffered a further hit this week with the news that it is to lose its head of oncology. 20 December 2016
Biotechnology
US biotech major Biogen has now selected a new chief executive to replace outgoing incumbent George Scangos, who has led the company since 2010 but announced his intention to leave last year, from its own ranks. 20 December 2016
Biotechnology
Genentech, the US-based biotech unit of Swiss pharma giant Roche, has announced its new chief executive after the retirement of Ian Clark. 16 December 2016
Pharmaceutical
Troubled Valeant Pharmaceuticals has announced the departure of three executives, as the business continues to restructure at the close of a punishing 2016. 14 December 2016
Biotechnology
Shares of US biotech firm Alexion Pharmaceuticals plunged as much as 15.6% to $111.44 on Monday, after it was revealed that its chief executive David Hallal had resigned for personal reasons, and chief financial officer Vikas Sinha was leaving to pursue other opportunities. 13 December 2016
Pharmaceutical
Effective February 1, 2017, Robert LaCaze will become executive vice president of the new Oncology Strategic Business unit at the Pharmaceuticals Division of German pharma major Bayer. 13 December 2016
Pharmaceutical
A new man is at the helm of the European Federation of Pharmaceutical Industries and Association (EFPIA) after the departure of Richard Bergström. 12 December 2016
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze